Currently, pancreatic adenocarcinoma mainly occurs after 60 years of age, and its prognosis
remains poor despite modest improvements in recent decades. The aging of the population …

Pain prevalence in cancer patients: status quo or opportunit... : Current Opinion in
Supportive and Palliative Care Pain prevalence in cancer patients: status quo or …

Pain is a highly prevalent symptom in patients with cancer. Despite therapeutic advances
and well-accepted treatment guidelines, a percentage of patients with pain are under …

Background Neurolytic splanchnic nerve block is used to manage pancreatic cancer pain.
However, its impact on survival and quality of life remains controversial. The authors' primary …

In this paper, we present the current guidelines for the diagnostics and management of
pancreatic neuroendocrine neoplasms (PanNENs) developed by Polish experts providing …

Abstract Purpose of Review Chronic abdominal pain (CAP) is a significant health problem
that can dramatically affect quality of life and survival. Pancreatic cancer is recognized as …

Opinion statement Despite extensive research that has identified new risk factors, genetic
mutations, and therapeutic options, pancreatic ductal adenocarcinoma continues to be a …

Purpose To perform a systematic review and meta-analysis of publications to evaluate the
analgesic efficacy and safety of percutaneous splanchnic nerve neurolysis (SNN) for cancer …

Tissue ablation techniques have emerged as a critical component of modern medical
practice and biomedical research, offering versatile solutions for treating various diseases …

Cancer pain is most commonly classified as nociceptive (somatic or visceral) or neuropathic.
Different types of pain or pain syndromes are present in all phases of cancer (early and …